6.17 USD
↘ 0.08 (1.28%)AT CLOSE (11:59 AM EDT)
Sionna Therapeutics, Inc. Common Stock
SIONNASDAQ • USD
6.17
↗ 0.00 (0.02%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
6.17
↗ 0.00 (0.02%)
Market: CLOSED
Shares of Sionna Therapeutics, Inc. Common Stock (SION) are trading at $6.18. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, SION appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 26, 2026.
Open?$6.20
High?$6.29
Low?$6.02
Prev. Close?$6.25
Volume?926.3K
Avg. Volume?3.2M
VWAP?$6.15
Rel. Volume?0.29x
Bid / Ask
Bid?$5.17 × 100
Ask?$7.05 × 100
Spread?$1.88
Midpoint?$6.11
Valuation & Ratios
Market Cap?282.6M
Shares Out?45.2M
Float?8.3M
Float %?18.5%
P/E Ratio?N/A
P/B Ratio?1.06
EPS?-$2.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
Employees
59
Market Cap
282.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-02-07
Address
21 HICKORY DRIVE, SUITE 500
WALTHAM, MA 02451
Phone: 617-819-2020
WALTHAM, MA 02451
Phone: 617-819-2020
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?55
Piotroski F-Score?0/9Weak
Altman Z-Score?7.75Safe
Confidence?41%Low
Short InterestSqueeze Risk
Short % of Float?51.34%Squeeze Risk
Short Interest?4.2M
Days to Cover?1.0
Free Float8.3M
Avg Daily Volume7.4M
Settlement Date2026-08-14
Financial Health
Current Ratio?20.05Strong
Quick Ratio?20.05Strong
Cash Ratio?5.87Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.06CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-36.6%WEAK▾
S&P3
ROA?-34.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-76207000
Enterprise Value?$219.3M
Fundamentals ratios updated end of day